BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 27379919)

  • 1. Impact of chronic kidney disease on clinical outcomes in patients with non-ST elevation myocardial infarction receiving percutaneous coronary intervention - A five-year observational study.
    Wang HT; Chen YL; Wu CJ
    Int J Cardiol; 2016 Oct; 220():166-72. PubMed ID: 27379919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-ST-Segment-Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score-Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management.
    Bhatia S; Arora S; Bhatia SM; Al-Hijji M; Reddy YNV; Patel P; Rihal CS; Gersh BJ; Deshmukh A
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29525779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Chronic Kidney Disease on Utilization of Coronary Angiography and Percutaneous Coronary Intervention, and Their Outcomes in Patients With Non-ST Elevation Myocardial Infarction.
    Murray J; Balmuri A; Saurav A; Smer A; Alla VM
    Am J Cardiol; 2018 Dec; 122(11):1830-1836. PubMed ID: 30336930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry.
    Bagai A; Lu D; Lucas J; Goyal A; Herzog CA; Wang TY; Goodman SG; Roe MT
    J Am Heart Assoc; 2018 Dec; 7(24):e010394. PubMed ID: 30514137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
    Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
    Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
    Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
    Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
    BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of electrocardiographic morphology on clinical outcomes in patients with non-ST elevation myocardial infarction receiving coronary angiography and intervention: a retrospective study.
    Wu CJ; Yeh KH; Wang HT; Liu WH; Chen HC; Chai HT; Chung WJ; Hsueh S; Chen CJ; Fang HY; Chen YL
    PeerJ; 2020; 8():e8796. PubMed ID: 32419982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-month clinical outcomes of acute non-ST versus ST-segment elevation myocardial infarction patients with reduced preprocedural thrombolysis in myocardial infarction flow undergoing percutaneous coronary intervention.
    Baek JY; Kang TS; Rha SW; Choi BG; Park SH; Jeong MH
    Coron Artery Dis; 2018 Aug; 29(5):416-422. PubMed ID: 29708887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of successful revascularization of coronary chronic total occlusions on long-term clinical outcomes in patients with non-ST-segment elevation myocardial infarction.
    Teng HI; Sung SH; Huang SS; Pan JP; Lin SJ; Chan WL; Lee WL; Lu TM; Wu CH
    J Interv Cardiol; 2018 Jun; 31(3):302-309. PubMed ID: 29495125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of delayed hospitalization on 3-year clinical outcomes according to renal function in patients with non-ST-segment elevation myocardial infarction.
    Kim YH; Her AY; Rha SW; Choi CU; Choi BG; Kim JB; Park S; Kang DO; Park JY; Park SH; Jeong MH
    Cardiol J; 2024; 31(2):271-284. PubMed ID: 37246457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
    Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
    BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
    Wasilewski J; Desperak P; Hawranek M; Ciślak A; Osadnik T; Pyka Ł; Gawlita M; Bujak K; Niedziela J; Krawczyk M; Gąsior M
    Platelets; 2016 Jul; 27(5):452-8. PubMed ID: 26939525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Predictive Roles of Risk Scores of In-Hospital Major Adverse Cardiovascular Events in Patients with Non-ST Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Aktürk E; Aşkın L; Taşolar H; Türkmen S; Kaya H
    Med Princ Pract; 2018; 27(5):459-465. PubMed ID: 29672288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of prognostic significance of mean platelet volume/platelet count with GRACE for long-term prognosis in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Yu T; Dong Y; Sun Z; Sun Z
    Int J Cardiol; 2017 Feb; 228():335-340. PubMed ID: 27866024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of sigma shaped right coronary artery is an indicator of poor prognosis in patients with inferior myocardial infarction treated with primary percutaneous coronary intervention.
    Güngör B; Alper AT; Ozcan KS; Ekmekçi A; Karadeniz FÖ; Mutluer FO; Kaya A; Karataş B; Osmonov D; Bolca O
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):965-72. PubMed ID: 24402881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study.
    Montalescot G; Collet JP; Ecollan P; Bolognese L; Ten Berg J; Dudek D; Hamm C; Widimsky P; Tanguay JF; Goldstein P; Brown E; Miller DL; LeNarz L; Vicaut E;
    J Am Coll Cardiol; 2014 Dec; 64(24):2563-2571. PubMed ID: 25524333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.